YL
Therapeutic Areas
Ataraxis AI Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Ataraxis Breast | Breast Cancer Prognosis & Treatment Response | Commercial |
| Kestrel | Pan-Cancer Digital Pathology Feature Extraction | Development |
Leadership Team at Ataraxis AI
JW
Jan Witowski
Chief Executive Officer & Co-Founder
KG
Krzysztof Geras
Chief Scientist & Co-Founder
LP
Lajos Pusztai
Clinical Advisory Board Member, Co-Director of the Yale Breast Center
FJ
Francisco J. Esteva
Clinical Advisory Board Member, Chief of Breast Medical Oncology at Northwell Health Lenox Hill